» Articles » PMID: 31376462

Renin-angiotensin-system, a Potential Pharmacological Candidate, in Acute Respiratory Distress Syndrome During Mechanical Ventilation

Overview
Specialty Pulmonary Medicine
Date 2019 Aug 4
PMID 31376462
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

While effective treatments for acute respiratory distress syndrome (ARDS) are lacking, mechanical lung ventilation can sustain adequate gas exchange in critically ill patients with respiratory failure due to ARDS. However, as a result of the phenomenon of ventilator-induced lung injury (VILI), there is an increasing need to seek beneficial pharmacological therapies for ARDS. Recent studies have suggested the renin-angiotensin system (RAS), which consists of the ACE/Ang-II/AT1R axis and ACE2/Ang-(1-7)/MasR axis, plays a dual role in the pathogenesis of ARDS and VILI. This review highlights the deleterious action of ACE/Ang-II/AT1R axis and the beneficial role of ACE2/Ang-(1-7)/MasR axis, as well as AT2R, in VILI and ARDS, and also discusses the possibility of targeting RAS components with pharmacological interventions to improve outcomes in ARDS.

Citing Articles

Unlocking the protective potential of the angiotensin type 2 receptor (ATR) in acute lung injury and age-related pulmonary dysfunction.

Abadir P, Cosarderelioglu C, Damarla M, Malinina A, Dikeman D, Marx R Biochem Pharmacol. 2023; 220:115978.

PMID: 38081369 PMC: 10880333. DOI: 10.1016/j.bcp.2023.115978.


Combined angiotensin-converting enzyme and aminopeptidase inhibition for treatment of experimental ventilator-induced lung injury in mice.

Mao X, Tretter V, Zhu Y, Kraft F, Vigl B, Poglitsch M Front Physiol. 2023; 14:1109452.

PMID: 37064885 PMC: 10097933. DOI: 10.3389/fphys.2023.1109452.


Downregulation of ACE, AGTR1, and ACE2 genes mediating SARS-CoV-2 pathogenesis by gut microbiota members and their postbiotics on Caco-2 cells.

Ahmadi Badi S, Malek A, Paolini A, Rouhollahi Masoumi M, Seyedi S, Amanzadeh A Microb Pathog. 2022; 173(Pt A):105798.

PMID: 36174833 PMC: 9511898. DOI: 10.1016/j.micpath.2022.105798.


Editorial: Protecting the acutely injured lung: Physiologic, mechanical, inflammatory, and translational perspectives.

Nieman G, Cereda M, Camporota L, Habashi N Front Physiol. 2022; 13:1009294.

PMID: 36148299 PMC: 9486833. DOI: 10.3389/fphys.2022.1009294.


Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.

El-Arif G, Khazaal S, Farhat A, Harb J, Annweiler C, Wu Y Molecules. 2022; 27(7).

PMID: 35408447 PMC: 9000463. DOI: 10.3390/molecules27072048.


References
1.
Brower R, Matthay M, Morris A, Schoenfeld D, Thompson B, Wheeler A . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301-8. DOI: 10.1056/NEJM200005043421801. View

2.
Tsantes A, Kopterides P, Bonovas S, Bagos P, Antonakos G, Nikolopoulos G . Effect of angiotensin converting enzyme gene I/D polymorphism and its expression on clinical outcome in acute respiratory distress syndrome. Minerva Anestesiol. 2013; 79(8):861-70. View

3.
Vukelic S, Griendling K . Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift. Circ Res. 2014; 114(5):754-7. PMC: 3985550. DOI: 10.1161/CIRCRESAHA.114.303045. View

4.
Konigshoff M, Wilhelm A, Jahn A, Sedding D, Amarie O, Eul B . The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am J Respir Cell Mol Biol. 2007; 37(6):640-50. DOI: 10.1165/rcmb.2006-0379TR. View

5.
Klein N, Gembardt F, Supe S, Kaestle S, Nickles H, Erfinanda L . Angiotensin-(1-7) protects from experimental acute lung injury. Crit Care Med. 2013; 41(11):e334-43. DOI: 10.1097/CCM.0b013e31828a6688. View